Jul 5, 2019

Trump says he'll issue executive order on drug prices

Trump talks to reporters at the White House Friday. Photo: Alex Wong/Getty Images

President Trump told reporters Friday that he plans to issue an executive order creating a "favored nations clause," where the U.S. would pay no more for a drug than the lowest price paid by another country.

Why it matters: There are a lot of details that are unclear, such as how the order would be enforced and how much of a difference it would make. But it's a sign that Trump wants to use his executive authority to move ahead on his campaign promise to lower drug prices — and a bad sign for drug companies.

Transcript of Trump's remarks, per the White House pool report:

"We're going to be announcing something very shortly, a favored nations clause. As you know, for years and years other nations paid less for drugs than we do. Sometimes by 60-70 percent.

"We're working on it right now, we're working on a favored nations clause, where we pay whatever the lowest nation’s price is.

"Why should other nations — like Canada — but why should other nations pay much less than us. They've taken advantage of the system for a long time, pharma. 

"But we're working on right now a favored nations clause, so that whatever the lowest nation is anywhere in the world, or company, but the lowest nation or company, then what happens is, we will pay that amount. And that’s being worked on right now. We're gonna do it in the form of an executive order."

Go deeper

Tech's long hot summer of antitrust

Illustration: Aïda Amer/Axios

Google, Facebook and other tech giants face a summer of regulatory grilling as long-running investigations into potential anticompetitive practices likely come to a head.

The big picture: Probes into the power of Big Tech launched by federal and state authorities are turning a year old, and observers expect action in the form of formal lawsuits and potentially damning reports — even as the companies have become a lifeline for Americans during the pandemic lockdown.

Palantir CEO hits Silicon Valley "monoculture," may leave California

Palantir is "getting close" to a decision on whether to move the company out of California, CEO Alex Karp said in an interview for "Axios on HBO."

The state of play: "We haven't picked a place yet, but it's going to be closer to the East Coast than the West Coast. ... If I had to guess, I would guess something like Colorado."

A reckoning for Russia's space program

Illustration: Aïda Amer/Axios

SpaceX's first attempt at launching astronauts from American soil this week is a historic moment that will stress the decades-long relationship between the U.S. and Russia in space.

Why it matters: Since the Cold War, the U.S. and Russia have collaborated intimately in space. As the U.S. regains the ability to launch people with its own rockets, the future of Russia's already struggling civil space program — and how the U.S. will collaborate with it — is unclear.